Clinical Study

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients

Table 3

Association of CCI with positive biopsy and tumor grade.

Univariate (95% CI) valueMultivariate (95% CI) value

Positive biopsy* (OR) 1.13 (0.80, 1.59)0.50 1.42 (0.75, 2.71)0.28
Gleason score (OR)
 Gleason 611
 Gleason 72.37 (0.88, 6.37)0.094.06 (1.04, 15.89)0.04
 Gleason 8–102.58 (0.97, 6.83)0.064.52 (1.16, 17.54)0.03

OR: odds ratio, CI: confidence interval, CCI: Charlson Comorbidity Index, PSA: prostate-specific antigen.
*Logistic regression analysis; multivariable analysis adjusted for age, race, log-transformed PSA, and BMI.
Multinomial logistic regression analysis; multivariable analysis adjusted for BMI, race, and log-transformed PSA.